Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Citi
Chubb
Johnson and Johnson
Cerilliant
UBS
Daiichi Sankyo
Covington

Generated: June 20, 2018

DrugPatentWatch Database Preview

BETOPTIC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for BETOPTIC
Synonyms for BETOPTIC
(+-)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol hydrochloride
1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol hydrochloride
1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanolhydrochloride
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)-
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-,hydrochloride
63659-18-7 (Parent)
63659-19-8
659X198
72424-72-7
A803574
AB2000314
AC-1412
AC1L331T
AC1Q3DQ4
AKOS015843993
alo 1401-02
AN-14973
API0001701
AS-18082
B 5683
B4474
BC227944
BCP0726000249
BCP9000394
Betaxolo Hydrochloride
Betaxolol (hydrochloride)
Betaxolol for peak identification, European Pharmacopoeia (EP) Reference Standard
Betaxolol HCL
Betaxolol hydrochloride
Betaxolol hydrochloride (Betoptic)
Betaxolol hydrochloride (JP17/USP)
Betaxolol hydrochloride [USAN:USP:JAN]
Betaxolol hydrochloride [USAN]
Betaxolol hydrochloride, >98% (HPLC)
Betaxolol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Betaxolol hydrochloride, United States Pharmacopeia (USP) Reference Standard
Betaxolol(hydrochloride)
Betaxololhydrochloride
Betoptic (TN)
Betoptic S
Betoptima
BG0105
CCG-101057
CCG-213473
CHDPSNLJFOQTRK-UHFFFAOYSA-N
CHEBI:643228
CHEMBL1691
CPD000058420
CS-2453
CTK8F0839
D00598
EINECS 264-384-3
EU-0100193
FT-0645228
HMS1569M05
HY-B0381A
I06-1154
Kerlon
Kerlone
Kerlone (TN)
Kerlong
KS-00001F73
Lokren
Lokren ,Kerlone ;Betoptic
LP00193
LS-122006
MCI-144
MFCD00242959
MLS000028464
MLS000758269
MLS000863279
MLS001148209
MLS001424199
MLS002222261
MolPort-003-666-823
NC00307
NCGC00093669-01
NCGC00093669-02
NCGC00260878-01
NSC-760048
NSC760048
Opera_ID_878
Pharmakon1600-01505512
Prestwick_779
Q-200714
S1827
SAM001247084
SCHEMBL42794
SL 75 212-10
SL 75.212-10
SL-75212-10
SMR000058420
SR-01000000108
SR-01000000108-4
ST51051256
TC-071428
Tox21_500193
W0012

US Patents and Regulatory Information for BETOPTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon BETOPTIC PILO betaxolol hydrochloride; pilocarpine hydrochloride SUSPENSION/DROPS;OPHTHALMIC 020619-001 Apr 17, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for BETOPTIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Healthtrust
McKinsey
Cipla
Fuji
Fish and Richardson
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.